Skip to search formSkip to main contentSkip to account menu

Budesonide / formoterol

Known as: BUDESONIDE/FORMOTEROL, formoterol and budesonide 
National Institutes of Health

Related topics

Related topics

2 relations
Budesonideformoterol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Clinical, physiological, and radiological features of asthma–chronic obstructive pulmonary disease overlap syndrome
Background Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is associated with rapid decline in lung… 
Review
2013
Review
2013
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.
BACKGROUND Both long-acting beta(2)-agonists and inhaled corticosteroids have been recommended in guidelines for the treatment of… 
Review
2007
Review
2007
Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease.
BACKGROUND Long-acting beta-agonists and inhaled corticosteroids have both been recommended in guidelines for the treatment of… 
Highly Cited
2006
Highly Cited
2006
Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial.
STUDY OBJECTIVE To compare a novel asthma management strategy--budesonide/formoterol in a single inhaler for both maintenance… 
Highly Cited
2006
Highly Cited
2006
Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma.
Highly Cited
2003
Highly Cited
2003
Combination Therapy with Single Inhaler Budesonide/Formoterol Compared with High Dose of Fluticasone Propionate Alone in Patients with Moderate Persistent Asthma
BackgroundThe efficacy and safety of Symbicort®1 (budesonide and formoterol in a single inhaler) were compared with those of a… 
Highly Cited
2003
Highly Cited
2003
Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma.
Patients with moderate persistent asthma (n = 523; mean FEV1 77.4%) not fully controlled with inhaled corticosteroids (ICS; 400… 
Highly Cited
2003
Highly Cited
2003
BUDESONIDE/FORMOTEROL ADJUSTABLE MAINTENANCE DOSING REDUCES ASTHMA EXACERBATIONS VERSUS FIXED DOSING
A guided, adjustable‐dosing regimen with budesonide/formoterol was investigated in asthma patients. In a randomised, open… 
Highly Cited
2002
Highly Cited
2002
Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma
The aim of this study was to evaluate the efficacy (expressed as effect on lung function) and tolerability of Symbicort… 
Highly Cited
2001
Highly Cited
2001
Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers.
Combinations of inhaled glucocorticoids and long-acting beta2-agonists in the same inhaler device have become available in recent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)